Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

Clinical trial NCT00329160 · COMPLETED

Trial details

NCT number: NCT00329160
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypercholesteremia

Start date: 2005-10-01
Primary completion: 2008-10-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.